Incomplete defect filling after third generation autologous chondrocyte implantation

被引:5
|
作者
Niethammer, Thomas R. [1 ]
Pietschmann, Matthias F. [1 ]
Ficklscherer, Andreas [1 ]
Guelecyuez, Mehmet F. [1 ]
Hammerschmid, Florian [1 ]
Mueller, Peter E. [1 ]
机构
[1] Univ Hosp Munich LMU, Dept Orthopaed Surg Phys Med & Rehabil, Munich, Germany
关键词
autologous chondrocyte implantation; cartilage defect; incomplete defect filling; MESENCHYMAL PROGENITOR CELLS; CARTILAGE THICKNESS; KNEE; TRANSPLANTATION; OSTEOARTHRITIS; JOINT;
D O I
10.5114/aoms.2016.60967
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Third generation autologous chondrocyte implantation (ACI) is a suitable method for the treatment of cartilage defects in the knee joint. However, knowledge about the development of graft thickness and the clinical relevance of incomplete defect filling in the postoperative course is low. This prospective study analyses the graft integration into the surrounding cartilage, with special consideration of the graft thickness. Material and methods: A total of 71 consecutive patients with 79 cartilage defects were treated with third generation autologous chondrocyte implantation (NOVOCART 3D) in the knee. Follow-up magnetic resonance imaging (MRI) was performed at 0.25, 0.5, 1 and 2 years. Graft thickness was measured compared to the surrounding healthy cartilage. The International Knee Documentation Committee (IKDC) scoring system and the visual analogue scale (VAS) were used for clinical evaluation. Cartilage defect filling was classified as the percentage of the surrounding cartilage. Results: The average graft thickness showed a significant increase between 3 and 6 months after autologous chondrocyte implantation. Incomplete defect filling occurred in 44 (55.7%) cases. Of these, 33 cases showed incomplete defect filling grade I (> 75%), 10 cases were grade II (> 50%) and one case grade III (> 25%). Incomplete defect filling grade IV (< 25%) was not observed. Incomplete defect filling occurred significantly more often in women (p = 0.021), without worse clinical results. Conclusions: Graft thickness after third generation autologous chondrocyte implantation shows increasing graft thickness over the period of 2 years postoperatively. A high rate of incomplete defect filling in the surrounding cartilage was observed, without worse clinical results.
引用
收藏
页码:785 / 792
页数:8
相关论文
共 50 条
  • [1] Revision surgery after third generation autologous chondrocyte implantation in the knee
    Thomas Niethammer
    Siegfried Valentin
    Andreas Ficklscherer
    Mehmet Gülecyüz
    Matthias Pietschmann
    Peter Müller
    International Orthopaedics, 2015, 39 : 1615 - 1622
  • [2] Revision surgery after third generation autologous chondrocyte implantation in the knee
    Niethammer, Thomas
    Valentin, Siegfried
    Ficklscherer, Andreas
    Guelecyuez, Mehmet
    Pietschmann, Matthias
    Mueller, Peter
    INTERNATIONAL ORTHOPAEDICS, 2015, 39 (08) : 1615 - 1622
  • [3] Erratum to: Revision surgery after third generation autologous chondrocyte implantation in the knee
    Thomas R. Niethammer
    Siegfried Valentin
    Andreas Ficklscherer
    Mehmet F. Gülecyüz
    Matthias F. Pietschmann
    Peter E. Müller
    International Orthopaedics, 2015, 39 : 1883 - 1883
  • [4] Effect of the defect localization and size on the success of third-generation autologous chondrocyte implantation in the knee joint
    Niethammer, Thomas R.
    Gallik, David
    Chevalier, Y.
    Holzgruber, Martin
    Baur-Melnyk, Andrea
    Mueller, Peter E.
    Pietschmann, Matthias F.
    INTERNATIONAL ORTHOPAEDICS, 2021, 45 (06) : 1483 - 1491
  • [5] Effect of the defect localization and size on the success of third-generation autologous chondrocyte implantation in the knee joint
    Thomas R. Niethammer
    David Gallik
    Y. Chevalier
    Martin Holzgruber
    Andrea Baur-Melnyk
    Peter E. Müller
    Matthias F. Pietschmann
    International Orthopaedics, 2021, 45 : 1483 - 1491
  • [6] Therapeutic strategy of third-generation autologous chondrocyte implantation for osteoarthritis
    Kuroda, Tomoya
    Matsumoto, Tomoyuki
    Mifune, Yutaka
    Fukui, Tomoaki
    Kubo, Seiji
    Matsushita, Takehiko
    Asahara, Takayuki
    Kurosaka, Masahiro
    Kuroda, Ryosuke
    UPSALA JOURNAL OF MEDICAL SCIENCES, 2011, 116 (02) : 107 - 114
  • [7] Third generation autologous chondrocyte implantation is a good treatment option for athletic persons
    Thomas Richard Niethammer
    Daniel Altmann
    Martin Holzgruber
    Sophia Goller
    Andreas Fischer
    Peter Ernst Müller
    Knee Surgery, Sports Traumatology, Arthroscopy, 2021, 29 : 1215 - 1223
  • [8] Third generation autologous chondrocyte implantation is a good treatment option for athletic persons
    Niethammer, Thomas Richard
    Altmann, Daniel
    Holzgruber, Martin
    Goller, Sophia
    Fischer, Andreas
    Mueller, Peter Ernst
    KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY, 2021, 29 (04) : 1215 - 1223
  • [9] Patient -Reported and Magnetic Resonance Imaging Outcomes of Third -Generation Autologous Chondrocyte Implantation After 10 Years
    Niethammer, Thomas R.
    Altmann, Daniel
    Holzgruber, Martin
    Guelecyuez, Mehmet F.
    Notohamiprodjo, Susan
    Baur-Melnyk, Andrea
    Mueller, Peter E.
    ARTHROSCOPY-THE JOURNAL OF ARTHROSCOPIC AND RELATED SURGERY, 2020, 36 (07): : 1928 - 1938
  • [10] Revision surgery after third generation autologous chondrocyte implantation in the knee (vol 39, pg 1615, 2015)
    Niethammer, Thomas R.
    Valentin, Siegfried
    Ficklscherer, Andreas
    Guelecyuez, Mehmet F.
    Pietschmann, Matthias F.
    Mueller, Peter E.
    INTERNATIONAL ORTHOPAEDICS, 2015, 39 (09) : 1883 - 1883